Cas13 therapy (Carver Biosciences)

N/A

Report date: 2025/08/15 17:43:07

Base Information

Drug NameCas13 therapy (Carver Biosciences)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Gene editing > CRISPR > CRISPR-Cas13
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRNA Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCarver Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesCarver Biosciences Inc
Inactive CompaniesN/A
Active IndicationsRNA Virus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A